Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
15,392,157
-
Total 13F shares
-
13,265,527
-
Share change
-
+1,130,440
-
Total reported value
-
$482,740,885
-
Price per share
-
$36.39
-
Number of holders
-
66
-
Value change
-
+$37,444,033
-
Number of buys
-
40
-
Number of sells
-
29
Institutional Holders of Neurogene Inc. - Common Stock (NGNE) as of Q2 2024
As of 30 Jun 2024 Neurogene Inc. - Common Stock (NGNE) had 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,265,527 shares of stock of the company.
Largest 10 holders included BlackRock Inc., EcoR1 Capital, LLC, Samsara BioCapital, LLC, RTW INVESTMENTS, LP, Redmile Group, LLC, GREAT POINT PARTNERS LLC, JANUS HENDERSON GROUP PLC, Avidity Partners Management LP, VANGUARD GROUP INC, and Casdin Capital, LLC.
This table shows 66 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.